Covid-19: FDA expert panel recommends authorising molnupiravir but also voices concerns
An advisory panel of experts has voted by 13 to 10 to recommend that the US Food and Drug Administration should grant an emergency authorisation to Merck’s molnupiravir (Lagevrio), an antiviral for…
